Gifu University · University Hospital · 助教

Research keywordsbreast cancer・neoadjuvant chemotherapy・trastuzumab deruxtecan・HER2-positive disease・breast reconstruction・radiofrequency ablation・osteoprotegerin signaling

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report.
• Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.
• p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
• Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy.

• Official profile
• ORCID